Mechanistic modelling of bioavailability and local immunogenicity after subcutaneous administration within the Open Systems Pharmacology framework PAGE 31 (2023) Abstr 10497 Pellowe M, Selvaggio G, Chenel M, Sjögren E. ConferenceImmunologyPBPK/PBBMQSP Pharmetheus Affiliates Director, MIDD Consultant Moriah Pellowe See bio Director, MIDD Consultant Gianluca Selvaggio See bio Chief Research Officer Marylore Chenel See bio Principal Director, PBPK & PBBM Scientific Lead Erik Sjögren See bio
